Articles from: Reuters
Investment in clean energy will extend its lead over spending on fossil fuels in 2023, the International Energy Agency said on Thursday, with solar...
-
Solar power due to overtake oil production investment for first time, IEA says https://t.co/64E29AhqMd - view on twitter
OpenAI has no plans to leave Europe, CEO Sam Altman said on Friday, reversing a threat made earlier this week to leave the region...
-
RT @SpirosMargaris: ChatGPT-maker @OpenAI says has no #plans to leave #Europe https://t.co/irSvhwj2DA #fintech #regulation @sama #AI #Art… - view on twitter
Britain’s automated border control gates have returned to normal operation, the Home Office said on Saturday, after a nationwide system issue caused major...
-
RT @ReutersWorld: Britain says border e-gates back in service after outage sparked delays https://t.co/Km0I6R9JW6 https://t.co/Km0I6R9JW6 - view on twitter
A passenger on an Asiana Airlines flight told police he opened a door on the plane minutes before it landed in Daegu, South Korea,...
-
RT @ReutersWorld: Man who opened Asiana plane door in mid-air tells police he was 'uncomfortable,' Yonhap reports https://t.co/HehXIOoGcM h… - view on twitter
Mashup Score:1
ReutersSolar power due to overtake oil production investment for first time, IEA says - 1 day
Mashup Score:1
Investment in clean energy will extend its lead over spending on fossil fuels in 2023, the International Energy Agency said on Thursday, with solar...
-
Solar power due to overtake oil production investment for first time, IEA says | Reuters https://t.co/dgGo4O36a8 - view on twitter
Sun Pharmaceutical Industries Ltd , India’s largest drugmaker by revenue, on Friday reported a 29.6% rise in fourth-quarter profit, as it benefited from lower...
-
Sun Pharmaceutical Industries Ltd , India's largest drugmaker by revenue, on Friday reported a 29.6% rise in fourth-quarter profit, as it benefited from lower expenses and higher sales of specialty drugs. https://t.co/ZjMEB3wCLZ - view on twitter
Mashup Score:1
ReutersU.S. FDA approves Lexicon Pharma’s drug for heart failure - 1 day
Mashup Score:1
The U.S. Food and Drug Administration (FDA) has approved Lexicon Pharmaceuticals Inc’s drug for a broad treatment of heart failure, including in adult patients...
-
The U.S. Food and Drug Administration (FDA) has approved Lexicon Pharmaceuticals Inc's drug for a broad treatment of heart failure, including in adult patients with type 2 diabetes, the company said on Friday. https://t.co/6Tz7ISlpZM - view on twitter
Sun Pharmaceutical Industries Ltd , India’s largest drugmaker by revenue, on Friday reported a 29.6% rise in fourth-quarter profit, as it benefited from lower...
-
Sun Pharmaceutical Industries Ltd , India's largest drugmaker by revenue, on Friday reported a 29.6% rise in fourth-quarter profit, as it benefited from lower expenses and higher sales of specialty drugs. https://t.co/hJJ91cjyjr - view on twitter
The U.S. Food and Drug Administration (FDA) has approved Lexicon Pharmaceuticals Inc’s drug for a broad treatment of heart failure, including in adult patients...
-
The U.S. Food and Drug Administration (FDA) has approved Lexicon Pharmaceuticals Inc's drug for a broad treatment of heart failure, including in adult patients with type 2 diabetes, the company said on Friday. https://t.co/EzJHNwlcKv - view on twitter
China’s market regulator said on Sunday it had fined two pharmaceutical companies for monopolistic...
China's market regulator said on Sunday it had fined two pharmaceutical companies for monopolistic behaviour. https://t.co/7ePBd7b8fV - view on twitter